Genetic Engineering & Biotechnology News

JAN15 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 6 of 29

Therapeutic Antibody Discovery by Mammalian Display Using directed integration of antibody genes by CRISPR/Cas9 and TALENs, the construction of large libraries in mammalian cells containing a single antibody gene/cell has been achieved. This accomplishment has enabled the construction of libraries containing millions of monoclonal, stable, cell lines displaying IgG-formatted antibodies on their surface, and from which novel, high-affinity binders can be isolated. This technology also allows for the selection of antibodies with improved biophysical properties from libraries of variants. In this new GEN webinar, we will describe the innovative antibody discovery technology developed by IONTAS and demonstrate its potential to save time and effort downstream by addressing antibody developability issues during the initial phase of biotherapeutic discovery. A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists. Free Registration! Thursday January 25, 2018 8: 00 am PT 11:00 am ET 17:00 CET DURATION: 60 minutes COST: Complimentary Speakers John McCafferty, Ph.D. CEO and Founder IONTAS Payal Roychoudhury, Ph.D. Field Application Scientist MaxCyte Produced with support from Webinars

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - JAN15 2018